Brx Activators
Brx Activators are a diverse set of chemical compounds that enhance the functional activity of Brx through various signaling mechanisms. For instance, Forskolin, IBMX, and Rolipram all work by increasing intracellular levels of cAMP, which is a critical second messenger in the activation of protein kinase A (PKA). PKA then phosphorylates target proteins, including Brx, thereby enhancing its activity. Similarly, PGE2, through its action on G-protein-coupled receptors, also leads to increased cAMP levels and subsequent PKA activity, which indirectly promotes Brx activation. Anisomycin, a protein synthesis inhibitor, activates stress-activated protein kinases, which may lead to the phosphorylation and activation of Brx through stress response signaling pathways. SB 203580 and U0126, by inhibiting p38 MAPK and MEK respectively, potentially shift the equilibrium of cellular signaling towards alternative pathways that activate Brx.
Moreover, Ionomycin and Thapsigargin raise intracellular calcium levels, which might activate calcium-dependent kinases that subsequently stimulate Brx. Epigallocatechin gallate, by inhibiting competitive kinase signaling, allows for enhanced signaling through pathways that lead to Brx activation. LY294002, as a PI3K inhibitor, might indirectly enhance Brx activity by promoting the use of alternative signaling routes that activate Brx. Lastly, Sildenafil, through its inhibition of PDE5, prevents cGMP degradation, which could influence signaling cascades that result in Brx phosphorylation and activation. Collectively, these Brx Activators, by targeting specific signaling pathways, facilitate the enhancement of Brx mediated functions without direct interaction with the protein or its expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing the levels of cyclic AMP (cAMP) within cells. Elevated cAMP can enhance the activity of Brx by promoting PKA-mediated phosphorylation of proteins that may be part of Brx signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits multiple protein kinases, potentially reducing negative regulatory phosphorylation events and thereby enhancing the activity of Brx by alleviating inhibitory signals. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels in cells. This elevation can indirectly enhance Brx activity by stimulating PKA and PKG pathways that might intersect with Brx. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate multiple targets, potentially modulating Brx activity through downstream signaling events. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can lead to the stabilization and activation of various signaling molecules, potentially enhancing the activity of Brx. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels. The increased cAMP may enhance Brx activity through cAMP-dependent signaling pathways like the activation of PKA. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of Rho-associated protein kinase (ROCK). Inhibition of ROCK can lead to changes in cytoskeletal dynamics and cell motility, potentially enhancing Brx activity if Brx is involved in these cellular processes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective PKC inhibitor that, paradoxically, can enhance Brx activity by shifting the balance of phosphorylation events within cells to favor activation of Brx-related pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, resulting in elevated cGMP levels. This can enhance Brx activity via cGMP-dependent signaling pathways that Brx may be a part of. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs). This activation may enhance Brx activity by inducing stress responses in which Brx is potentially involved. | ||||||